Filing Details
- Accession Number:
- 0001104659-17-039277
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-14 19:17:50
- Reporting Period:
- 2017-06-13
- Filing Date:
- 2017-06-14
- Accepted Time:
- 2017-06-14 19:17:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410939 | Ophthotech Corp. | OPHT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1662720 | E David Redlick | C/O Ophthotech Corporation One Penn Plaza, 19Th Floor New York NY 10119 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-06-13 | 700 | $2.52 | 1,050 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2016.
- These shares were disposed of in multiple transactions on June 13, 2017 at actual sales prices ranging from $2.49 to $2.56 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
